Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 21-30 of 640 total displayed.

Past content (since Jan 1999):

Editorial Commentaries
Sodium Chloride and Aldosterone: Harbingers of Hypertension-Related Cardiovascular Disease
Theodore A. Kotchen
Hypertension 2009;54:449-450; published online before print as doi:10.1161/HYPERTENSIONAHA.109.136226 [Full text]  

Editorial Commentaries
Angiotensin-Converting Enzyme and Dipeptidyl Peptidase IV Inhibitors: An Increased Risk of Angioedema
Eric Grouzmann, Françoise Livio, and Thierry Buclin
Hypertension 2009;54:468-470; published online before print as doi:10.1161/HYPERTENSIONAHA.109.135244 [Full text]  

Original Articles
Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor
Matthias Löhn, Oliver Plettenburg, Yuri Ivashchenko, Aimo Kannt, Armin Hofmeister, Dieter Kadereit, Matthias Schaefer, Wolfgang Linz, Markus Kohlmann, Jean-Marc Herbert, Philip Janiak, Stephen E. O'Connor, and Hartmut Ruetten
Hypertension 2009;54:676-683; published online before print as doi:10.1161/HYPERTENSIONAHA.109.134353 [Abstract] [Full text]  

Scientific Contributions
Differences in the Magnitude of Wave Reflection Account for Differential Effects of Amlodipine- Versus Atenolol-Based Regimens on Central Blood Pressure. An Anglo-Scandinavian Cardiac Outcome Trial Substudy
Charlotte H. Manisty, Andrew Zambanini, Kim H. Parker, Justin E. Davies, Darrel P. Francis, Jamil Mayet, Simon A. McG Thom, Alun D. Hughes on behalf of the Anglo-Scandinavian Cardiac Outcome Trial Investigators
Hypertension published August 24, 2009, doi:10.1161/HYPERTENSIONAHA.108.125740 [Abstract]  

Editorial Commentaries
Protein Kinase C–Inhibiting Properties of the Losartan Metabolite EXP3179 Make the Difference
Philip Wenzel, Eberhard Schulz, and Thomas Münzel
Hypertension published August 17, 2009, doi:10.1161/HYPERTENSIONAHA.109.136218 [Abstract]  

Scientific Contributions
Magnetic Resonance Imaging Left Ventricular Mass Reduction With Fixed-Dose Angiotensin-Converting Enzyme Inhibitor–Based Regimens in Patients With High-Risk Hypertension
Nathaniel Reichek, Richard B. Devereux, Ricardo A. Rocha, Robert Hilkert, Donna Hall, Das Purkayastha, and Bertram Pitt
Hypertension published August 17, 2009, doi:10.1161/HYPERTENSIONAHA.109.130641 [Abstract]  

Scientific Contributions
Differential Effects Between a Calcium Channel Blocker and a Diuretic When Used in Combination With Angiotensin II Receptor Blocker on Central Aortic Pressure in Hypertensive Patients
Yoshio Matsui, Kazuo Eguchi, Michael F. O'Rourke, Joji Ishikawa, Hiroshi Miyashita, Kazuyuki Shimada, and Kazuomi Kario
Hypertension published August 10, 2009, doi:10.1161/HYPERTENSIONAHA.109.131466 [Abstract]  

Letters to the Editor
Response to Exercise Generates Lactate and Fluid Intake: Effects on Mitochondrial Function in Heart and Vascular Smooth Muscle
Masaaki Miyachi and Kohzo Nagata
Hypertension 2009;54:e15; published online before print as doi:10.1161/HYPERTENSIONAHA.109.135285 [Full text]  

Brief Reviews
Thiazide Effects and Adverse Effects: Insights From Molecular Genetics
David H. Ellison and Johannes Loffing
Hypertension 2009;54:196-202; published online before print as doi:10.1161/HYPERTENSIONAHA.109.129171 [Full text]  

Original Articles
Regulation of Proliferation and Membrane Potential by Chloride Currents in Rat Pulmonary Artery Smooth Muscle Cells
Wenbin Liang, Julie Basu Ray, Jeff Z. He, Peter H. Backx, and Michael E. Ward
Hypertension 2009;54:286-293; published online before print as doi:10.1161/HYPERTENSIONAHA.109.130138 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment